Expression and regulation of cyclic nucleotide phosphodiesterases in human and rat pancreatic islets

PLoS One. 2010 Dec 1;5(12):e14191. doi: 10.1371/journal.pone.0014191.

Abstract

As shown by transgenic mouse models and by using phosphodiesterase 3 (PDE3) inhibitors, PDE3B has an important role in the regulation of insulin secretion in pancreatic β-cells. However, very little is known about the regulation of the enzyme. Here, we show that PDE3B is activated in response to high glucose, insulin and cAMP elevation in rat pancreatic islets and INS-1 (832/13) cells. Activation by glucose was not affected by the presence of diazoxide. PDE3B activation was coupled to an increase as well as a decrease in total phosphorylation of the enzyme. In addition to PDE3B, several other PDEs were detected in human pancreatic islets: PDE1, PDE3, PDE4C, PDE7A, PDE8A and PDE10A. We conclude that PDE3B is activated in response to agents relevant for β-cell function and that activation is linked to increased as well as decreased phosphorylation of the enzyme. Moreover, we conclude that several PDEs are present in human pancreatic islets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cyclic Nucleotide Phosphodiesterases, Type 3 / biosynthesis*
  • Cyclic Nucleotide Phosphodiesterases, Type 3 / genetics
  • Diazoxide / pharmacology
  • Gene Expression Regulation, Enzymologic*
  • Glucose / metabolism
  • Humans
  • Insulin-Secreting Cells / cytology
  • Insulinoma / metabolism
  • Islets of Langerhans / enzymology*
  • Male
  • Phosphorylation
  • Rats
  • Rats, Sprague-Dawley
  • Species Specificity

Substances

  • Cyclic Nucleotide Phosphodiesterases, Type 3
  • Glucose
  • Diazoxide